HR+ HER2- Metastatic Breast Cancer: Can We Predict Outcomes?

20/02/2020 5 min

Listen "HR+ HER2- Metastatic Breast Cancer: Can We Predict Outcomes?"

Episode Synopsis

Hormone-sensitive breast tumors make up around 70% of all breast cancers. Associate Professor Aleix Prat explains what research is being conducted into this metastatic disease and how before we can find a cure, researchers are working in the short term to find a way to make it a chronic disease.